Price T Rowe Associates Inc Immunocore Holdings PLC Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,157,698 shares of IMCR stock, worth $70 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,157,698

Previous 2,832,669 23.83%

Holding current value

$70 Million

Previous $96 Million 30.03%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.06 - $41.49 $20.3 Million - $28 Million	-674,971 Reduced 23.83%	2,157,698 $67.2 Million
Q2 2024 Aug 14, 2024	BUY	$33.78 - $63.75 $13.3 Million - $25.2 Million	395,085 Added 16.21%	2,832,669 $96 Million
Q1 2024 May 15, 2024	SELL	$60.14 - $75.36 $30.5 Million - $38.2 Million	-506,990 Reduced 17.22%	2,437,584 $158 Million
Q4 2023 Feb 14, 2024	BUY	$42.85 - $69.5 $18.1 Million - $29.4 Million	423,290 Added 16.79%	2,944,574 $201 Million
Q3 2023 Nov 14, 2023	BUY	$49.5 - $66.6 $4.84 Million - $6.52 Million	97,864 Added 4.04%	2,521,284 $131 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $50.5 Million - $64.1 Million	1,039,980 Added 75.17%	2,423,420 $145 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $2.28 Million - $3.25 Million	49,524 Added 3.71%	1,383,440 $68.4 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $7.75 Million - $11.1 Million	170,355 Added 14.64%	1,333,916 $76.1 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $31.7 Million - $48.8 Million	849,662 Added 270.68%	1,163,561 $54.6 Million
Q2 2022 Aug 15, 2022	SELL	$25.46 - $37.72 $748,014 - $1.11 Million	-29,380 Reduced 8.56%	313,899 $11.7 Million
Q1 2022 May 16, 2022	SELL	$18.94 - $34.29 $693,431 - $1.26 Million	-36,612 Reduced 9.64%	343,279 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$27.58 - $40.0 $492,716 - $714,600	17,865 Added 4.93%	379,891 $13 Million
Q3 2021 Nov 15, 2021	SELL	$27.98 - $40.0 $147,678 - $211,120	-5,278 Reduced 1.44%	362,026 $13.4 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $41.5 $663,989 - $855,232	-20,608 Reduced 5.31%	367,304 $14.3 Million
Q1 2021 May 17, 2021	BUY	$36.3 - $56.34 $14.1 Million - $21.9 Million	387,912 New	387,912 $16.5 Million

Others Institutions Holding IMCR

# of Institutions

141

Shares Held

41.4M

Call Options Held

197K

Put Options Held

451K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.42B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Immunocore Holdings PLC Transaction History